Cargando…

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis

Vascular disrupting agents (VDAs) represent a novel approach to the treatment of cancer, resulting in the collapse of tumor vasculature and tumor death. 5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a VDA currently in advanced phase II clinical trials, yet its precise mechanism of action is unknow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Zachary J., Goutagny, Nadege, Perera, Pin-Yu, Kato, Hiroki, Kumar, Himanshu, Kawai, Taro, Akira, Shizuo, Savan, Ram, van Echo, David, Fitzgerald, Katherine A., Young, Howard A., Ching, Lai-Ming, Vogel, Stefanie N.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2007
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118649/ https://www.ncbi.nlm.nih.gov/pubmed/17562815 http://dx.doi.org/10.1084/jem.20061845

Ejemplares similares

The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant
por: Tang, Choon Kit, et al.
Publicado: (2013)

TANK-Binding Kinase 1 (TBK1) Isoforms Negatively Regulate Type I Interferon Induction by Inhibiting TBK1-IRF3 Interaction and IRF3 Phosphorylation
por: Hu, Yi Wei, et al.
Publicado: (2018)

Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins
por: Tsuchida, Tetsuo, et al.
Publicado: (2009)

Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon β
por: Bakshi, Siddharth, et al.
Publicado: (2017)

The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
por: Weiss, Julia M., et al.
Publicado: (2017)

PGAM5-MAVS interaction regulates TBK1/ IRF3 dependent antiviral responses
por: Yu, Yu-qiang, et al.
Publicado: (2020)

TBK1 and IRF3 are potential therapeutic targets in Enterovirus A71-associated diseases
por: Ji, Wangquan, et al.
Publicado: (2023)

The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis
por: Occhigrossi, Luca, et al.
Publicado: (2023)

A Novel Transcript Isoform of TBK1 Negatively Regulates Type I IFN Production by Promoting Proteasomal Degradation of TBK1 and Lysosomal Degradation of IRF3
por: Zhang, Jie, et al.
Publicado: (2020)

Thymoquinone Suppresses IRF-3-Mediated Expression of Type I Interferons via Suppression of TBK1
por: Aziz, Nur, et al.
Publicado: (2018)

Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway
por: Wang, Yan, et al.
Publicado: (2017)

UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway
por: Chen, Tianhong, et al.
Publicado: (2020)

Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7
por: Unterholzner, Leonie, et al.
Publicado: (2011)

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
por: Brown, Michael C., et al.
Publicado: (2021)

ERRα negatively regulates type I interferon induction by inhibiting TBK1-IRF3 interaction
por: He, Xiang, et al.
Publicado: (2017)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

Porcine Epidemic Diarrhea Virus nsp15 Antagonizes Interferon Signaling by RNA Degradation of TBK1 and IRF3
por: Wu, Yang, et al.
Publicado: (2020)

Identification of Small GTPases That Phosphorylate IRF3 through TBK1 Activation Using an Active Mutant Library Screen
por: Yu, Jae-Hyun, et al.
Publicado: (2023)

Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression
por: Rauca, Valentin-Florian, et al.
Publicado: (2021)

Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction
por: Ogasawara, Naotaka, et al.
Publicado: (2011)

cGAS/STING/TBK1/IRF3 Signaling Pathway Activates BMDCs Maturation Following Mycobacterium bovis Infection
por: Li, Qiang, et al.
Publicado: (2019)

Histone acetyl transferase TIP60 inhibits the replication of influenza a virus by activation the TBK1-IRF3 pathway
por: Ma, Guoyao, et al.
Publicado: (2018)

Palmitic Acid Promotes Virus Replication in Fish Cell by Modulating Autophagy Flux and TBK1-IRF3/7 Pathway
por: Yu, Yepin, et al.
Publicado: (2020)

Broadly Antiviral Activities of TAP1 through Activating the TBK1-IRF3-Mediated Type I Interferon Production
por: Zhao, Jin, et al.
Publicado: (2021)

The cGAS/STING–TBK1–IRF Regulatory Axis Orchestrates a Primitive Interferon-Like Antiviral Mechanism in Oyster
por: Qiao, Xue, et al.
Publicado: (2021)

CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes
por: Yang, Chao, et al.
Publicado: (2022)

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA
por: Henare, K, et al.
Publicado: (2012)

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011)

Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway
por: Black, Katharine E, et al.
Publicado: (2013)

Ste20-Like Kinase TAOK1 Positively Regulates Antiviral Responses by Controlling the TBK1-IRF3 Signaling Axis
por: Luo, Xiaogang, et al.
Publicado: (2023)

Binding-Pocket and Lid-Region Substitutions Render Human STING Sensitive to the Species-Specific Drug DMXAA
por: Gao, Pu, et al.
Publicado: (2014)

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
por: Drzyzga, Alina, et al.
Publicado: (2021)

Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway
por: Song, Jae-Hyoung, et al.
Publicado: (2019)

The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels
por: Basit, Abdul, et al.
Publicado: (2020)

TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections
por: Yum, Seoyun, et al.
Publicado: (2021)

Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
por: Deng, Tingjuan, et al.
Publicado: (2021)

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice
por: Zhao, L, et al.
Publicado: (2002)

Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
por: Tijono, S M, et al.
Publicado: (2013)

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2018)

Histone H2A Nuclear/Cytoplasmic Trafficking Is Essential for Negative Regulation of Antiviral Immune Response and Lysosomal Degradation of TBK1 and IRF3
por: Wu, Xiao Man, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_liir6cnmon5acaugeg3rlcd70a